Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring

Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring

Bibliographic Details
Main Author:	Swiss Medical Weekly
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2006-11-01
Series:	Swiss Medical Weekly
Subjects:	drug monitoring side effects Voriconazole
Online Access:	https://www.smw.ch/index.php/smw/article/view/671

Similar Items

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
by: Sacha Sarfati, et al.
Published: (2022-07-01)

The Role of Plasma Trough Concentration of Voriconazole and Voriconazole N-Oxide in Its Hepatotoxicity in Adult Patients
by: Cheng L, et al.
Published: (2024-08-01)

Voriconazole: a review of adjustment programs guided by therapeutic drug monitoring
by: Li Jiang, et al.
Published: (2024-12-01)

Recent Advances in Therapeutic Drug Monitoring of Voriconazole, Mycophenolic Acid, and Vancomycin: A Literature Review of Pediatric Studies
by: Matylda Resztak, et al.
Published: (2021-11-01)

Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events
by: Ben-Nian Huo, et al.
Published: (2024-09-01)

Associated factors with voriconazole plasma concentration: a systematic review and meta-analysis
by: Xiaoqi Li, et al.
Published: (2024-08-01)

Voriconazole Use in Children: Therapeutic Drug Monitoring and Control of Inflammation as Key Points for Optimal Treatment
by: José María Valle-T-Figueras, et al.
Published: (2021-06-01)

Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients
by: Zaiming Liang, et al.
Published: (2022-04-01)

Comparison of LC-MS<sup>3</sup> and LC-MRM Method for Quantifying Voriconazole and Its Application in Therapeutic Drug Monitoring of Human Plasma
by: Wenbo Ren, et al.
Published: (2022-08-01)

Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags
by: Andréa I.H. Adams, et al.

Association between voriconazole-induced visual hallucination and dopamine in an analysis of the food and drug administration (FDA) adverse event reporting system database
by: Hideo Kato, et al.
Published: (2024-05-01)

Treatment of graft versus host disease with photopheresis interferes in voriconazole therapeutic drug monitoring: A case study
by: Adriana Sassone, et al.
Published: (2023-11-01)

Pharmacogenetic Analysis of Voriconazole Treatment in Children
by: Romy Tilen, et al.
Published: (2022-06-01)

Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study
by: Mar Ronda, et al.
Published: (2023-06-01)

Comparison of clinical pharmacology of voriconazole and posaconazole
by: Beata M. Sienkiewicz, et al.
Published: (2016-12-01)

Evaluation of the tacrolimus drug interaction with voriconazole vs clotrimazole in heart transplant recipients
by: Elizabeth Posney, PharmD, et al.
Published: (2024-05-01)

High-Performance Liquid Chromatography for Ultra-Simple Determination of Plasma Voriconazole Concentration
by: Takeo Yasu, et al.
Published: (2022-09-01)

Voriconazole-induced periostitis in the hand
by: Gurbinder Singh, et al.
Published: (2025-03-01)

The Impact of Plasma Protein Binding Characteristics and Unbound Concentration of Voriconazole on Its Adverse Drug Reactions
by: Zi-Qing-Yun Yuan, et al.
Published: (2020-04-01)

Enhancing voriconazole therapy in liver dysfunction: exploring administration schemes and predictive factors for trough concentration and efficacy
by: Yichang Zhao, et al.
Published: (2024-01-01)

To compare the safety and efficacy of intrastromal voriconazole alone and in combination with intracameral voriconazole in intractable cases of fungal keratitis
by: Monika Dahiya, et al.
Published: (2023-08-01)

The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
by: Yi-Chang Zhao, et al.
Published: (2022-12-01)

Uso de voriconazol en el período neonatal. Reporte de dos casos = Voriconazole use during the neonatal period. Report of two cases
by: Carvajal Kalil, Luis Fernando, et al.
Published: (2011-06-01)

Interaction and potential mechanisms between atorvastatin and voriconazole, agents used to treat dyslipidemia and fungal infections
by: Tianrong Xun, et al.
Published: (2023-05-01)

Voriconazole-Induced Diffuse Periostitis
by: Simona Stefan, MD, et al.
Published: (2022-09-01)

Standardization and validation of a high-efficiency liquid chromatography with a diode-array detector (HPLC-DAD) for voriconazole blood level determination
by: Juan D. Zapata, et al.
Published: (2024-03-01)

Voriconazole-induced periostitis post lung transplantation
by: Orla M. Murray, Bsc, et al.
Published: (2022-05-01)

A Large Sample Retrospective Study on the Distinction of Voriconazole Concentration in Asian Patients from Different Clinical Departments
by: Yichang Zhao, et al.
Published: (2021-11-01)

Voriconazole-induced periostitis
by: D.C. Fernández Ávila, et al.
Published: (2021-04-01)

Pseudoporphyria Induced by Voriconazole in a 10-year-old Boy: A Case Report and Review of the Literature
by: Francesca Caroppo, et al.
Published: (2023-05-01)

Recurrent Acremonium infection in a kidney transplant patient treated with voriconazole: a case report Infecção recidivante por Acremonium em paciente transplantado renal tratado com voriconazol: relato de caso
by: Felipe Francisco Tuon, et al.
Published: (2010-08-01)

Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study
by: Qinghua Ye, et al.
Published: (2022-08-01)

Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis
by: Yuki Hanai, et al.
Published: (2021-04-01)

Factors influencing plasma concentration of voriconazole and voriconazole- N-oxide in younger adult and elderly patients
by: Lin Cheng, et al.
Published: (2023-02-01)

RP-HPTLC method for determination of Voriconazole in bulk and in cream formulation
by: Manali W. Jain, et al.
Published: (2017-02-01)

Comparison of ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and enzyme-multiplied immunoassay technique (EMIT) for quantification of voriconazole plasma concentration from Chinese patients
by: Mingjie Yu, et al.
Published: (2023-11-01)

Sustained Release of Voriconazole Using 3D-Crosslinked Hydrogel Rings and Rods for Use in Corneal Drug Delivery
by: Aiym Rakhmetova, et al.
Published: (2023-11-01)

Bronchoscopic Voriconazole Instillation in Pulmonary Aspergilloma: A Single Center Experience
by: Prajowl Shrestha, et al.
Published: (2019-06-01)

Natamycin versus voriconazole for fungal keratitis
by: José Retamal, et al.
Published: (2018-12-01)

Amphotericin B May Decrease the Serum Level of Voriconazole: A Case Report and Brief Review of Literature
by: Hu Z, et al.
Published: (2022-09-01)